Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 35.7730.8923.5130.6732.80

What is the latest EV/Core EBITDA ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 35.77 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202535.77
Mar202430.89
Mar202323.51
Mar202230.67
Mar202132.80

How is EV/Core EBITDA of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 35.77
15.80
Mar2024 30.89
31.39
Mar2023 23.51
-23.35
Mar2022 30.67
-6.49
Mar2021 32.8 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹54,924.6 Cr -1.2% -2.3% 27.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,289.0 Cr -0.4% -0.9% 4.8% Stock Analytics
DIVIS LABORATORIES ₹181,397.0 Cr -0.7% 1.6% 50.2% Stock Analytics
CIPLA ₹119,955.0 Cr -1.7% -1.1% -2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,132.0 Cr -1.1% 1.6% 13.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,657.0 Cr -4.3% -8% -4.4% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-1.2%

-2.3%

27.2%

SENSEX

-1.1%

-0%

3.2%


You may also like the below Video Courses